Evidence map›Paper›PMID 31052341›Full record

ReviewInternational journal of molecular sciences2019

Resveratrol and Vascular Function.

Huige Li, Ning Xia, Solveig Hasselwander, Andreas Daiber

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 1 pooled it
16.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 1 synthesis or guideline pooled it, 197 citations in OpenAlex.

  1. The Effects of Resveratrol on Menopausal Cardio-metabolic Changes: A Systematic Review.Cardiovascular & hematological disorders drug targets · 2026
    Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. The Role of the Gut Microbiota in Vascular Physiology and Health.International journal of molecular sciences · 2025
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Huige LiDepartment of Pharmacology, Johannes Gutenberg University Medical Center, 55131 Mainz, Germany. huigeli@uni-mainz.de.
Ning XiaDepartment of Pharmacology, Johannes Gutenberg University Medical Center, 55131 Mainz, Germany. xianing@uni-mainz.de.
Solveig HasselwanderDepartment of Pharmacology, Johannes Gutenberg University Medical Center, 55131 Mainz, Germany. sohassel@uni-mainz.de.
Andreas DaiberCenter for Cardiology, Cardiology I - Laboratory of Molecular Cardiology, Johannes Gutenberg University Medical Center, 55131 Mainz, Germany. daiber@uni-mainz.de.
Johannes Gutenberg University Mainz · DE

Funding

Boehringer Ingelheim Stiftung Research consortium "Novel and neglected cardiovascular risk factors: molecular mechanisms and therapeutic implications"Deutsche Forschungsgemeinschaft LI-1042/1-1Deutsche Forschungsgemeinschaft LI-1042/3-1
6 · The paper itself

Abstract

Resveratrol increases the production of nitric oxide (NO) in endothelial cells by upregulating the expression of endothelial NO synthase (eNOS), stimulating eNOS enzymatic activity, and preventing eNOS uncoupling. At the same time, resveratrol inhibits the synthesis of endothelin-1 and reduces oxidative stress in both endothelial cells and smooth muscle cells. Pathological stimuli-induced smooth muscle cell proliferation, vascular remodeling, and arterial stiffness can be ameliorated by resveratrol as well. In addition, resveratrol also modulates immune cell function, inhibition of immune cell infiltration into the vascular wall, and improves the function of perivascular adipose tissue. All these mechanisms contribute to the protective effects of resveratrol on vascular function and blood pressure in vivo. Sirtuin 1, AMP-activated protein kinase, and estrogen receptors represent the major molecules mediating the vascular effects of resveratrol.

Indexed as

AnimalsAntihypertensive AgentsAntioxidantsBlood PressureEndothelium, VascularHumansMuscle, Smooth, VascularResveratrolAntihypertensive AgentsAntioxidantsResveratrolcardiovascular diseaseendothelial nitic oxide synthaseendotheliumresveratrolsirtuin 1vascular function

Identifiers

PMID31052341
PMCPMC6539341
OpenAlexW2942819726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.